Nuo Therapeutics, Inc.
AURX
$1.23
$0.043.36%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 55.12% | -6.91% | -7.55% | 17.21% | 12.92% |
| Total Depreciation and Amortization | 10.68% | -2.83% | 2.91% | 1.23% | 24.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.41% | 112.38% | 52.40% | 74.87% | -6.83% |
| Change in Net Operating Assets | 57.25% | -3,748.28% | 104.19% | -133.20% | 23.53% |
| Cash from Operations | 69.85% | -85.59% | 40.18% | -369.25% | 14,477.78% |
| Capital Expenditure | -31,525.00% | 98.15% | -- | 100.00% | 99.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -31,525.00% | 98.15% | -- | 100.00% | 99.26% |
| Total Debt Issued | 35.00% | 0.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 35.00% | 0.00% | -44.75% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 165.06% | -936.07% | -82.81% | -23.90% | 214.29% |